Principal Financial Group Inc Global Blood Therapeutics, Inc. Transaction History

Principal Financial Group Inc

$172 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$32.4 - $68.18 $3,499 - $7,363	-108 Reduced 0.64%	16,835 $1.15 Million
Q2 2022 Aug 10, 2022	SELL	$22.3 - $37.39 $617,397 - $1.04 Million	-27,686 Reduced 62.04%	16,943 $541,000
Q1 2022 May 09, 2022	BUY	$25.68 - $35.59 $683,601 - $947,405	26,620 Added 147.81%	44,629 $1.55 Million
Q4 2021 Feb 09, 2022	SELL	$24.9 - $40.26 $171,610 - $277,471	-6,892 Reduced 27.68%	18,009 $527,000
Q3 2021 Nov 09, 2021	BUY	$25.48 - $37.34 $25,046 - $36,705	983 Added 4.11%	24,901 $635,000
Q2 2021 Aug 10, 2021	BUY	$32.46 - $43.42 $118,349 - $158,309	3,646 Added 17.99%	23,918 $837,000
Q1 2021 May 10, 2021	BUY	$38.94 - $50.85 $15,848 - $20,695	407 Added 2.05%	20,272 $826,000
Q4 2020 Feb 08, 2021	SELL	$37.65 - $63.77 $12,198 - $20,661	-324 Reduced 1.6%	19,865 $860,000
Q3 2020 Nov 06, 2020	SELL	$52.76 - $74.49 $81,514 - $115,087	-1,545 Reduced 7.11%	20,189 $1.11 Million
Q2 2020 Aug 05, 2020	BUY	$48.73 - $81.82 $256,514 - $430,700	5,264 Added 31.96%	21,734 $1.37 Million
Q1 2020 May 12, 2020	BUY	$41.72 - $87.2 $3,963 - $8,284	95 Added 0.58%	16,470 $842,000
Q4 2019 Feb 05, 2020	SELL	$45.7 - $81.86 $29,019 - $51,981	-635 Reduced 3.73%	16,375 $1.3 Million
Q3 2019 Nov 13, 2019	BUY	$45.35 - $57.91 $70,111 - $89,528	1,546 Added 10.0%	17,010 $825,000
Q2 2019 Aug 12, 2019	BUY	$52.6 - $63.29 $34,242 - $41,201	651 Added 4.39%	15,464 $813,000
Q1 2019 May 10, 2019	BUY	$39.99 - $53.48 $28,352 - $37,917	709 Added 5.03%	14,813 $784,000
Q4 2018 Feb 14, 2019	SELL	$31.54 - $46.67 $86,041 - $127,315	-2,728 Reduced 16.21%	14,104 $579,000
Q3 2018 Nov 14, 2018	BUY	$38.0 - $51.1 $93,594 - $125,859	2,463 Added 17.14%	16,832 $639,000
Q2 2018 Aug 13, 2018	BUY	$38.7 - $50.15 $54,373 - $70,460	1,405 Added 10.84%	14,369 $0
Q1 2018 May 14, 2018	BUY	$39.6 - $65.9 $2,930 - $4,876	74 Added 0.57%	12,964 $626,000
Q4 2017 Feb 13, 2018	BUY	$29.7 - $45.7 $382,833 - $589,073	12,890	12,890 $507,000

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account